IGF2 and obesity due to melanocortin 4 receptor deficiency: Our in vivo data confirms reduced IGF2 levels in obese mice and our in vitro work revealed the strong clinical application for deploying IGF2 in fertility clinics for ART purposes to increase the pregnancy outcomes by reducing meiotic defects associated with obesity.